In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Onc Now | Episode 20 In this special episode of Onc Now, host Jonathan Sackier is joined by Lennard Lee, Associate Professor of Cancer Vaccines at the University of Oxford, to explore the promise of ...

Now, mRNA vaccines can be quickly created against different antigenic targets by changing the mRNA sequence, and companies are looking beyond COVID-19 at other infectious diseases, including ...

Why are adult vaccines important, and what are some common misconceptions? The first question I usually get is, “Should I get this vaccine?” But the real question is, “Do I want the illness it ...

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring.

Treating types of cancer with CAR T-cell therapy is expensive and inconvenient, but a streamlined approach that creates the therapy within the body could make the intervention cheaper and easier ...

Researchers at Queen’s University of Belfast and collaborators have developed a DNA vaccine against high-grade serous ovarian cancer. The vaccine encodes PRAME, which the researchers found to be ...

IMUNON announces promising Phase 1 results for IMNN-101, a DNA plasmid vaccine demonstrating enhanced durability and potential advantages over mRNA vaccines.

And this growth story has been so solid in the past months that, during the company's recent earnings call, Chairman and Chief Technology Officer Larry Ellison made a very bold prediction.

A new kind of mRNA vaccine developed by researchers at the University of Pittsburgh and Penn State University could be cheaper to produce and offer a greater level of immunity across multiple ...